{"transactions":[{"id":1828227,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":111337,"kind":"organization","name":"AHAC Sponsor III LLC","position":1,"cik":"0001842917","reported_name":"AHAC Sponsor III LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2023-07-18T20:52:15.000Z","date":"2023-07-14","kind":"grant","planned":false,"acquired":true,"shares":115971,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"The warrants were purchased by the Sponsor on July 29, 2021. The warrants will become exercisable 30 days after the closing of the Business Combination."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The warrants were purchased by the Sponsor on July 29, 2021. The warrants will become exercisable 30 days after the closing of the Business Combination."}],"balance_after":115971,"derivative":{"exercise_price":11.5,"exercise_date":"2023-08-13","expiration_date":"2028-07-14","underlying":"Common Stock","underlying_shares":115971},"source":{"system":"sec-edgar","filing":"0001213900-23-057997","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1842917/000121390023057997/ownership.xml","form_type":"4"}},{"id":1828226,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":111337,"kind":"organization","name":"AHAC Sponsor III LLC","position":1,"cik":"0001842917","reported_name":"AHAC Sponsor III LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Common Stock","published_at":"2023-07-18T20:52:15.000Z","date":"2023-07-14","kind":"exercise","planned":false,"acquired":false,"shares":3786026,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"As described in the registration statement of Alpha Healthcare Acquisition Corp. III (the \"Issuer\") on Form S-1 (File No. 333-253876) under the heading \"Description of Securities,\" the shares of Class B common stock of the Issuer (\"Issuer Class B Common Stock\") will automatically convert into shares of Class A common stock of the Issuer (\"Issuer Class A Common Stock\") at the time of the Issuer's initial business combination on a one-for-one basis subject to certain adjustments and have no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"As described in the registration statement of Alpha Healthcare Acquisition Corp. III (the \"Issuer\") on Form S-1 (File No. 333-253876) under the heading \"Description of Securities,\" the shares of Class B common stock of the Issuer (\"Issuer Class B Common Stock\") will automatically convert into shares of Class A common stock of the Issuer (\"Issuer Class A Common Stock\") at the time of the Issuer's initial business combination on a one-for-one basis subject to certain adjustments and have no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On July 14, 2023, the Issuer consummated its initial business combination pursuant to the Business Combination Agreement, dated January 4, 2023 (the \"Business Combination Agreement\"), by and among the Issuer, Candy Merger Sub, Inc. (\"Merger Sub\") and Carmell Regen Med Corporation (formerly known as Carmell Therapeutics Corporation, \"Carmell\"), whereby Merger Sub merged with and into Carmell, with Carmell surviving the merger as a wholly-owned subsidiary of the Issuer, and the Issuer changed its name to Carmell Therapeutics Corporation (such merger and the transactions contemplated thereby, collectively, the \"Business Combination\"). In connection with the closing of the Business Combination, each share of Issuer Class B Common Stock automatically converted on a one-for-one basis into one share of Issuer Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"As described in the registration statement of Alpha Healthcare Acquisition Corp. III (the \"Issuer\") on Form S-1 (File No. 333-253876) under the heading \"Description of Securities,\" the shares of Class B common stock of the Issuer (\"Issuer Class B Common Stock\") will automatically convert into shares of Class A common stock of the Issuer (\"Issuer Class A Common Stock\") at the time of the Issuer's initial business combination on a one-for-one basis subject to certain adjustments and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On July 14, 2023, the Issuer consummated its initial business combination pursuant to the Business Combination Agreement, dated January 4, 2023 (the \"Business Combination Agreement\"), by and among the Issuer, Candy Merger Sub, Inc. (\"Merger Sub\") and Carmell Regen Med Corporation (formerly known as Carmell Therapeutics Corporation, \"Carmell\"), whereby Merger Sub merged with and into Carmell, with Carmell surviving the merger as a wholly-owned subsidiary of the Issuer, and the Issuer changed its name to Carmell Therapeutics Corporation (such merger and the transactions contemplated thereby, collectively, the \"Business Combination\"). In connection with the closing of the Business Combination, each share of Issuer Class B Common Stock automatically converted on a one-for-one basis into one share of Issuer Class A Common Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"As described in the registration statement of Alpha Healthcare Acquisition Corp. III (the \"Issuer\") on Form S-1 (File No. 333-253876) under the heading \"Description of Securities,\" the shares of Class B common stock of the Issuer (\"Issuer Class B Common Stock\") will automatically convert into shares of Class A common stock of the Issuer (\"Issuer Class A Common Stock\") at the time of the Issuer's initial business combination on a one-for-one basis subject to certain adjustments and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On July 14, 2023, the Issuer consummated its initial business combination pursuant to the Business Combination Agreement, dated January 4, 2023 (the \"Business Combination Agreement\"), by and among the Issuer, Candy Merger Sub, Inc. (\"Merger Sub\") and Carmell Regen Med Corporation (formerly known as Carmell Therapeutics Corporation, \"Carmell\"), whereby Merger Sub merged with and into Carmell, with Carmell surviving the merger as a wholly-owned subsidiary of the Issuer, and the Issuer changed its name to Carmell Therapeutics Corporation (such merger and the transactions contemplated thereby, collectively, the \"Business Combination\"). In connection with the closing of the Business Combination, each share of Issuer Class B Common Stock automatically converted on a one-for-one basis into one share of Issuer Class A Common Stock."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":3786026},"source":{"system":"sec-edgar","filing":"0001213900-23-057997","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1842917/000121390023057997/ownership.xml","form_type":"4"}},{"id":1828225,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":111337,"kind":"organization","name":"AHAC Sponsor III LLC","position":1,"cik":"0001842917","reported_name":"AHAC Sponsor III LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-07-18T20:52:15.000Z","date":"2023-07-14","kind":"other","planned":false,"acquired":true,"shares":4249908,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Pursuant to the Issuer's Third Amended and Restated Certificate of Incorporation filed in connection with the closing of the Business Combination, the Issuer completed a reclassification exempt under Rule 16b-7 (the \"Reclassification\"). In accordance with the Reclassification, each share of Issuer Class A Common Stock was reclassified on a one-for-one basis into one share of common stock of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Issuer's Third Amended and Restated Certificate of Incorporation filed in connection with the closing of the Business Combination, the Issuer completed a reclassification exempt under Rule 16b-7 (the \"Reclassification\"). In accordance with the Reclassification, each share of Issuer Class A Common Stock was reclassified on a one-for-one basis into one share of common stock of the Issuer."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"AHAC Sponsor III LLC (the \"Sponsor\") is the record holder of the shares reported herein. Rajiv Shukla, the Issuer's Executive Chairman of the Board of Directors, is the managing member of the Sponsor and may be deemed the beneficial owner of the shares held by the Sponsor. Mr. Shukla disclaims beneficial ownership over any securities in which he does not have a pecuniary interest."}],"balance_after":4249908,"source":{"system":"sec-edgar","filing":"0001213900-23-057997","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1842917/000121390023057997/ownership.xml","form_type":"4"}},{"id":1828224,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":111337,"kind":"organization","name":"AHAC Sponsor III LLC","position":1,"cik":"0001842917","reported_name":"AHAC Sponsor III LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-07-18T20:52:15.000Z","date":"2023-07-14","kind":"other","planned":false,"acquired":false,"shares":4249908,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Pursuant to the Issuer's Third Amended and Restated Certificate of Incorporation filed in connection with the closing of the Business Combination, the Issuer completed a reclassification exempt under Rule 16b-7 (the \"Reclassification\"). In accordance with the Reclassification, each share of Issuer Class A Common Stock was reclassified on a one-for-one basis into one share of common stock of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Issuer's Third Amended and Restated Certificate of Incorporation filed in connection with the closing of the Business Combination, the Issuer completed a reclassification exempt under Rule 16b-7 (the \"Reclassification\"). In accordance with the Reclassification, each share of Issuer Class A Common Stock was reclassified on a one-for-one basis into one share of common stock of the Issuer."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"AHAC Sponsor III LLC (the \"Sponsor\") is the record holder of the shares reported herein. Rajiv Shukla, the Issuer's Executive Chairman of the Board of Directors, is the managing member of the Sponsor and may be deemed the beneficial owner of the shares held by the Sponsor. Mr. Shukla disclaims beneficial ownership over any securities in which he does not have a pecuniary interest."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001213900-23-057997","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1842917/000121390023057997/ownership.xml","form_type":"4"}},{"id":1828223,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":111337,"kind":"organization","name":"AHAC Sponsor III LLC","position":1,"cik":"0001842917","reported_name":"AHAC Sponsor III LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-07-18T20:52:15.000Z","date":"2023-07-14","kind":"exercise","planned":false,"acquired":true,"shares":3786026,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"As described in the registration statement of Alpha Healthcare Acquisition Corp. III (the \"Issuer\") on Form S-1 (File No. 333-253876) under the heading \"Description of Securities,\" the shares of Class B common stock of the Issuer (\"Issuer Class B Common Stock\") will automatically convert into shares of Class A common stock of the Issuer (\"Issuer Class A Common Stock\") at the time of the Issuer's initial business combination on a one-for-one basis subject to certain adjustments and have no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On July 14, 2023, the Issuer consummated its initial business combination pursuant to the Business Combination Agreement, dated January 4, 2023 (the \"Business Combination Agreement\"), by and among the Issuer, Candy Merger Sub, Inc. (\"Merger Sub\") and Carmell Regen Med Corporation (formerly known as Carmell Therapeutics Corporation, \"Carmell\"), whereby Merger Sub merged with and into Carmell, with Carmell surviving the merger as a wholly-owned subsidiary of the Issuer, and the Issuer changed its name to Carmell Therapeutics Corporation (such merger and the transactions contemplated thereby, collectively, the \"Business Combination\"). In connection with the closing of the Business Combination, each share of Issuer Class B Common Stock automatically converted on a one-for-one basis into one share of Issuer Class A Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"As described in the registration statement of Alpha Healthcare Acquisition Corp. III (the \"Issuer\") on Form S-1 (File No. 333-253876) under the heading \"Description of Securities,\" the shares of Class B common stock of the Issuer (\"Issuer Class B Common Stock\") will automatically convert into shares of Class A common stock of the Issuer (\"Issuer Class A Common Stock\") at the time of the Issuer's initial business combination on a one-for-one basis subject to certain adjustments and have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On July 14, 2023, the Issuer consummated its initial business combination pursuant to the Business Combination Agreement, dated January 4, 2023 (the \"Business Combination Agreement\"), by and among the Issuer, Candy Merger Sub, Inc. (\"Merger Sub\") and Carmell Regen Med Corporation (formerly known as Carmell Therapeutics Corporation, \"Carmell\"), whereby Merger Sub merged with and into Carmell, with Carmell surviving the merger as a wholly-owned subsidiary of the Issuer, and the Issuer changed its name to Carmell Therapeutics Corporation (such merger and the transactions contemplated thereby, collectively, the \"Business Combination\"). In connection with the closing of the Business Combination, each share of Issuer Class B Common Stock automatically converted on a one-for-one basis into one share of Issuer Class A Common Stock."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"AHAC Sponsor III LLC (the \"Sponsor\") is the record holder of the shares reported herein. Rajiv Shukla, the Issuer's Executive Chairman of the Board of Directors, is the managing member of the Sponsor and may be deemed the beneficial owner of the shares held by the Sponsor. Mr. Shukla disclaims beneficial ownership over any securities in which he does not have a pecuniary interest."}],"balance_after":4249908,"source":{"system":"sec-edgar","filing":"0001213900-23-057997","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1842917/000121390023057997/ownership.xml","form_type":"4"}},{"id":2606049,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":111337,"kind":"organization","name":"AHAC Sponsor III LLC","position":1,"cik":"0001842917","reported_name":"AHAC Sponsor III LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"CLASS A COMMON STOCK","published_at":"2021-08-12T16:07:55.000Z","date":"2021-08-06","kind":"other","acquired":true,"shares":8882,"price":10,"value":88820.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of 8,882 units purchased by AHAC Sponsor III LLC (the \"Sponsor\") for $10.00 per unit in a private placement transaction with the registrant, pursuant to the partial over-allotment exercise of the underwriters. Each such unit consists of one share of Class A common stock and one fourth of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The Sponsor is the record holder of the shares reported herein. Rajiv Shukla, the issuer's Chief Executive Officer, is the managing member of the Sponsor and may be deemed the beneficial owner of the shares held by the Sponsor. Mr. Shukla disclaims beneficial ownership over any securities in which he does not have a pecuniary interest."}],"balance_after":463882,"source":{"system":"sec-edgar","filing":"0001213900-21-042018","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1842917/000121390021042018/ownership.xml","form_type":"4"}},{"id":2618940,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":111337,"kind":"organization","name":"AHAC Sponsor III LLC","position":1,"cik":"0001842917","reported_name":"AHAC Sponsor III LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"CLASS A COMMON STOCK","published_at":"2021-08-03T09:10:33.000Z","date":"2021-07-29","kind":"other","acquired":true,"shares":455000,"price":10,"value":4550000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of 455,000 units purchased by AHAC Sponsor III LLC (the \"Sponsor\") for $10.00 per unit in a private placement transaction with the registrant. Each such unit consists of one share of Class A common stock and one fourth of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The Sponsor is the record holder of the shares reported herein. Rajiv Shukla, the issuer's Chief Executive Officer, is the managing member of the Sponsor and may be deemed the beneficial owner of the shares held by the Sponsor. Mr. Shukla disclaims beneficial ownership over any securities in which he does not have a pecuniary interest."}],"balance_after":455000,"source":{"system":"sec-edgar","filing":"0001213900-21-039980","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1842917/000121390021039980/ownership.xml","form_type":"4"}}]}